Compare MDA & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MDA | MMSI |
|---|---|---|
| Founded | 1969 | 1987 |
| Country | Canada | United States |
| Employees | 4000 | N/A |
| Industry | Electronic Components | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.2B | 4.0B |
| IPO Year | 2026 | 1996 |
| Metric | MDA | MMSI |
|---|---|---|
| Price | $30.35 | $67.11 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $37.50 | ★ $98.88 |
| AVG Volume (30 Days) | ★ 608.6K | 524.4K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 4.93 |
| EPS | N/A | ★ 2.13 |
| Revenue | N/A | ★ $1,515,906,000.00 |
| Revenue This Year | $12.11 | $8.85 |
| Revenue Next Year | $11.03 | $5.88 |
| P/E Ratio | ★ N/A | $31.68 |
| Revenue Growth | N/A | ★ 11.75 |
| 52 Week Low | $23.23 | $63.78 |
| 52 Week High | $37.45 | $99.26 |
| Indicator | MDA | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 45.09 | 43.96 |
| Support Level | $23.23 | $66.76 |
| Resistance Level | $33.75 | $71.68 |
| Average True Range (ATR) | 1.72 | 2.05 |
| MACD | -0.41 | -0.15 |
| Stochastic Oscillator | 16.54 | 43.85 |
MDA Space Ltd is a developer and manufacturer of technology and services to the space industry. It is an international space mission partner and robotics, satellite systems, and geo-intelligence pioneer. It is engaged in communications satellites, Earth and space observation, space exploration, and infrastructure. The Company collaborates and partners with governments and space agencies, commercial space companies, and defence and aerospace prime contractors in the space industry. Geographically, it generates the majority of its revenue from Canada.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.